Structure of Solifenacin
CAS No.: 242478-37-1
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
Solifenacin is a competitive antagonist of muscarinic receptors that potently blocks signaling through M1, M2, and M3 with Kis of 25, 125, and 10 nM, respectively.
Synonyms: YM905 free base; YM905
4.5
*For Research Use Only !
Change View
| Size | Price | VIP Price |
DE Stock US Stock |
Asia Stock Global Stock |
In Stock |
| {[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | {[ item.p_spot_brand_remark ]} 1-2 weeks {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.p_spot_brand_remark ]} 1-2 weeks {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock Inquiry - | Login - + |
Please Login or Create an Account to: See VIP prices and availability
Asia Stock: Ship in 3-5 business days
EU Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
{[ item.p_spot_brand_remark ]}
1-2weeks
Inquiry
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ item.p_spot_brand_remark ]}
1-2weeks
Inquiry
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
Asia Stock: Ship in 3-5 business days
EU Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
| CAS No. : | 242478-37-1 |
| Formula : | C23H26N2O2 |
| M.W : | 362.46 |
| SMILES Code : | C(O[C@@H]1C2CCN(C1)CC2)(=O)N3[C@H](C=4C(CC3)=CC=CC4)C5=CC=CC=C5 |
| Synonyms : |
YM905 free base; YM905
|
| MDL No. : | MFCD18910847 |
| InChI Key : | FBOUYBDGKBSUES-VXKWHMMOSA-N |
| Pubchem ID : | 154059 |
| GHS Pictogram: |
|
| Signal Word: | Warning |
| Hazard Statements: | H361 |
| Precautionary Statements: | P201-P202-P280-P308+P313-P405-P501 |
| Target |
|
In Vivo:
| Administration | Dosage | Frequency | Description | References |
| Sprague-Dawley rats | Capacity-reduced bladder model | Intra-arterial injection | 10 μg/kg-0.1 mg/kg | Single bolus | Solifenacin significantly improved bladder compliance in the capacity-reduced bladder model, reduced voiding frequency, and increased voided volume. | Front Pharmacol. 2021 May 26;12:657959 |
Clinical Trial:
| NCT Number | Conditions | Phases | Recruitment | Completion Date | Locations |
| NCT01122563 | Overactive Bladder | COMPLETED | 2025-01-11 | Bandung, Indonesia|Jakarta, In... More >>donesia|Surabaya, Indonesia Less << | |
| NCT01018511 | Benign Prostatic Hyperplasia ... More >> Lower Urinary Tract Symptoms Less << | Phase 3 | Completed | - | - |
| NCT01457573 | Lower Urinary Tract Symptoms | Phase 4 | Completed | - | United States, Texas ... More >> The Methodist Hospital System Houston, Texas, United States, 77030 Less << |
| NCT01021332 | Lower Urinary Tract Symptoms ... More >> Benign Prostatic Hyperplasia Less << | Phase 3 | Completed | - | - |
| NCT01953861 | EC905 Pharmac... More >>okinetics Healthy Subjects Less << | Phase 1 | Completed | - | United Kingdom ... More >> Parexel Early Phase Clinical Unit Harrow, United Kingdom, H1 3UJ Less << |
| NCT00189800 | Overactive Bladder | Phase 3 | Completed | - | Korea, Republic of ... More >> Anyang, Korea, Republic of Bucheon, Korea, Republic of Busan, Korea, Republic of Cheonan, Korea, Republic of Daegu, Korea, Republic of Daejeon, Korea, Republic of Gwangju, Korea, Republic of Incheon, Korea, Republic of Seoul, Korea, Republic of Suwon, Korea, Republic of Less << |
| NCT01018511 | - | Completed | - | - | |
| NCT01767519 | Overactive Bladder ... More >> Urinary Incontinence Less << | Phase 3 | Completed | - | United States, California ... More >> Newport Beach, California, United States Belgium Leuven, Belgium Canada, British Columbia Vancouver, British Columbia, Canada Canada, Ontario Toronto, Ontario, Canada Czech Republic Prague 6, Czech Republic Germany Berlin, Germany Poland Warsaw, Poland United Kingdom London, United Kingdom Less << |
| NCT00441428 | - | Completed | - | Italy ... More >> University of L'Aquila L'Aquila, Abruzzo, Italy, 67100 Less << | |
| NCT01457573 | - | Completed | - | - | |
| NCT01767519 | - | Completed | - | - | |
| NCT01737918 | Surgical Treatment of Urge Inc... More >>ontinence Less << | Phase 1 Phase 2 | Unknown | July 2018 | Germany ... More >> Abt. Beckenbodenchirurgie der Universitäts-Frauenklinik Köln Recruiting Köln, NRW, Germany, 50931 Contact: Wolfram H Jager, PhD 0049221478 ext 4900 wolfram.jaeger@uk-koeln.de Abt. Beckenbodenchirurgie der Universitäts-Frauenklinik Köln Recruiting Köln, NRW, Germany, 50931 Contact: Wolfram H Jager, PhD 0049221478 ext 4900 wolfram.jaeger@uk-koeln.de Contact: Peter Mallmann, PhD 0049221478 ext 4940 peter.mallmann@uk-koeln.de Principal Investigator: Wolfram H Jager, PhD Less << |
| NCT02494349 | LUTS(Lower Urinary Tract Sympt... More >>oms) Benign Prostatic Hyperplasia Overactive Bladder Less << | Phase 1 | Completed | - | - |
| NCT01021332 | - | Completed | - | - | |
| NCT01340027 | Urologic Diseases ... More >> Urinary Bladder Diseases Urological Manifestations Signs and Symptoms Urinary Bladder, Overactive Less << | Phase 2 | Completed | - | - |
| NCT03038321 | Non-Muscle-invasive Bladder Ca... More >>ncer (NMIBC) Bacillus Calmette-Guerin (BCG) Cystitis Intra-vesical Instillation Less << | Phase 4 | Active, not recruiting | December 2019 | Egypt ... More >> Urology and Nephrology Center Mansoura, Aldakahlia, Egypt, 35516 Less << |
| NCT00826527 | Urinary Frequency ... More >> Urinary Urgency Nocturia Less << | Phase 4 | Unknown | - | United States, Washington ... More >> Seattle Urology Research Center Recruiting Seattle, Washington, United States, 98166 Contact: Angel J Felipa, Coordinator 206-243-3701 surc@comcast.net Principal Investigator: Jeffrey M Frankel, MD Less << |
| NCT01639794 | - | Completed | - | Ireland ... More >> Site 2 - Mercy University Hospital Cork, Ireland Site: 4 - Tallaght Hospital Dublin, Ireland, 24 Site: 1 - St James Hopsital Dublin, Ireland, 8 Site: 5 - Beaumont Hospital Dublin, Ireland, 9 Site: 3 - Sligo General Hospital Sligo, Ireland Less << | |
| NCT00801944 | Urinary Bladder, Overactive | Phase 3 | Completed | - | - |
| NCT00333112 | Urinary Incontinence | Phase 4 | Completed | - | - |
| NCT01340027 | - | Completed | - | - | |
| NCT00909428 | Overactive Bladder Syndrome | Phase 4 | Completed | - | United States, Illinois ... More >> Loyola University Medical Center Maywood, Illinois, United States, 60153 Less << |
| NCT00909428 | - | Completed | - | - | |
| NCT00584090 | Urinary Incontinence ... More >> Parkinson's Disease Less << | Phase 4 | Withdrawn(Study withdrawn with... More >> intent of persuing larger, multi-site study.) Less << | - | United States, Florida ... More >> University of South Florida Tampa, Florida, United States, 33612 Less << |
| NCT01799902 | Lower Urinary Tract Predominan... More >>t Storage Symptoms Less << | COMPLETED | 2025-10-13 | ASZ, Aalst, 9300, Belgium|ZNA ... More >>Stuyvenberg, Antwerpen, 2060, Belgium|Erasme, Brussel, 1070, Belgium|UZ Brussel, Brussel, 1090, Belgium|Private practice, Brussel, 1180, Belgium|AZ St. Monica, Deurne, 2100, Belgium|UZ Antwerpen, Edegem, 2650, Belgium|Maria Middelares, Gent, 9000, Belgium|Sint-Lucas, Gent, 9000, Belgium|UZ Gent, Gent, 9000, Belgium|AZ Groeninge, Kortrijk, 8500, Belgium|AZ Damiaan, Oostende, 8400, Belgium|AZ Oudenaarde, Oudenaarde, 9700, Belgium|H.Hart Roeselaere, Roeselaere, 8800, Belgium|AZ Sint Elisabeth, Zottegem, 9620, Belgium Less << | |
| NCT00573508 | Urinary Bladder, Overactive | Phase 4 | Completed | - | - |
| NCT00832650 | Healthy | Phase 1 | Terminated(Protocol A0221057 w... More >>as terminated on December 25, 2009 for futility. There were no safety concerns related to this decision.) Less << | - | United States, Minnesota ... More >> Pfizer Investigational Site Rochester, Minnesota, United States, 55905 Less << |
| NCT00832650 | - | Terminated(Protocol A0221057 w... More >>as terminated on December 25, 2009 for futility. There were no safety concerns related to this decision.) Less << | - | - | |
| NCT01972841 | - | Completed | - | - | |
| NCT02667470 | Overactive Bladder | PHASE4 | COMPLETED | 2025-05-13 | Site: 1, Bangkok, 10330, Thail... More >>and Less << |
| NCT01126424 | Cognition | Phase 4 | Completed | - | United Kingdom ... More >> Blackpool, Lancashire, United Kingdom, FY2 0JH Manchester, Lancashire, United Kingdom, M50 2GY Bradford, Yorkshire, United Kingdom, BD3 0DQ Less << |
| NCT00368706 | Urinary Bladder, Overactive | Phase 3 | Completed | - | China ... More >> Beijing, China, 100000 Chong Qing, China, 404000 Hang Zhou, China, 310000 Shanghai, China, 200000 Less << |
| NCT00852696 | Overactive Bladder | Phase 4 | Completed | - | United States, Florida ... More >> Cleveland Clinic Florida Weston, Florida, United States, 33331 Less << |
| NCT00510406 | Lower Urinary Tract Symptoms ... More >> Prostatic Hyperplasia Less << | Phase 2 | Completed | - | - |
| NCT01972841 | Urinary Bladder Overactive ... More >> Urinary Bladder Diseases\Urologic Diseases Overactive Bladder Urgency Incontinence Less << | Phase 3 | Completed | - | - |
| NCT01953848 | EC905 Pharmac... More >>okinetics Multiple Dose Healthy Subjects Less << | Phase 1 | Completed | - | United Kingdom ... More >> Parexel Early Phase Clinical Unit Harrow, United Kingdom, H1 3UJ Less << |
| NCT01126424 | - | Completed | - | - | |
| NCT00454896 | Urinary Bladder, Overactive | Phase 3 | Completed | - | - |
| NCT00573508 | - | Completed | - | - | |
| NCT00629642 | Multiple Sclerosis ... More >> Neurogenic Bladder Spinal Cord Diseases Less << | Phase 4 | Completed | - | - |
| NCT00699049 | Urinary Bladder, Overactive | Phase 4 | Completed | - | Korea, Republic of ... More >> Cheonan, Korea, Republic of Pusan, Korea, Republic of Seoul, Korea, Republic of Less << |
| NCT01908829 | Urinary Bladder Diseases ... More >> Urinary Bladder Overactive Urologic Diseases Less << | Phase 3 | Completed | - | - |
| NCT00759577 | Overactive Bladder | PHASE4 | TERMINATED | 2025-05-10 | - |
| NCT01908829 | - | Completed | - | - | |
| NCT00771394 | Benign Prostatic Hyperplasia ... More >> Benign Prostatic Hypertrophy Overactive Bladder Less << | Phase 4 | Completed | - | Japan ... More >> Chubu, Japan Chugoku, Japan Hokkaido, Japan Kansai, Japan Kantou, Japan Kyushu, Japan Shikoku, Japan Touhoku, Japan Less << |
| NCT00759577 | Overactive Bladder | PHASE4 | TERMINATED | 2025-05-10 | - |
| NCT02094703 | Urinary Tract Infection | Phase 4 | Unknown | December 2014 | Indonesia ... More >> Cipto Mangunkusumo Hospital Recruiting Jakarta, Indonesia, 10430 Contact: Harrina Erlianti Rahardjo +62 816-825-226 harrinaerlianti@yahoo.com Less << |
| NCT02634489 | Phase 1 Healt... More >>hy Benign Prostatic Hyperplasia Lower Urinary Tract Symptoms Less << | Phase 1 | Completed | - | Netherlands ... More >> Site NL1 Zuidlaren, Drente, Netherlands, 9471 GP Less << |
| NCT01381120 | Flank Pain Ur... More >>inary Bladder, Overactive Less << | Phase 4 | Completed | - | Canada, Ontario ... More >> Barrie Urology Associates - The Male/Female Health and Research Centre Barrie, Ontario, Canada, L4M 7G1 Less << |
| NCT01880619 | Relieve of Ureteral Stent Symp... More >>toms Less << | Phase 4 | Completed | - | Egypt ... More >> Urology and Nephrology Center Mansoura, Egypt, 35516 Less << |
| NCT00802373 | Urinary Bladder, Overactive | Phase 3 | Completed | - | - |
| NCT01381120 | - | Completed | - | - | |
| NCT01539707 | Overactive Bladder ... More >> Neurogenic Detrusor Overactivity Less << | Phase 1 | Completed | - | Belgium ... More >> Site: 3201 Gent, Belgium, 9000 Canada, Quebec Québec City, Quebec, Canada, G1V 4G2 Denmark Site: 4501 Århus N, Denmark, DK-8200 Netherlands Site: 3102 Utrecht, Netherlands, 3584 EA Poland Site: 4801 Warszawa, Poland, 04-730 Turkey Site: 90 Ankara, Turkey, 6100 United Kingdom Site: 44 Sheffield, United Kingdom, S10 2TH Less << |
| NCT01642277 | Overactive Bladder | PHASE2 | COMPLETED | 2025-08-14 | Loyola University Chicago Heal... More >>th Sciences Division, Maywood, Illinois, 60153, United States Less << |
| NCT03149809 | Overactive Bladder ... More >> Parkinson Disease Less << | Phase 3 | Recruiting | December 31, 2021 | United States, Alabama ... More >> Birmingham VA Medical Center, Birmingham, AL Recruiting Birmingham, Alabama, United States, 35233 Contact: Galen Hale 205-933-8101 ext 5637 galen.hale@va.gov Contact: Alayne D Markland, MD 2055587067 ext 6365 alayne.markland@va.gov United States, Georgia Atlanta VA Medical and Rehab Center, Decatur, GA Recruiting Decatur, Georgia, United States, 30033 Contact: Elizabeth C Vaughan, MD MS (404) 321-6111 ext 3710 elizabeth.vaughan2@va.gov Principal Investigator: Elizabeth Camille Vaughan, MD MS United States, Virginia Hunter Holmes McGuire VA Medical Center, Richmond, VA Recruiting Richmond, Virginia, United States, 23249 Contact: George Gitchel, PhD 804-675-6300 george.gitchel@va.gov Contact: Jessica Lehosit, MD 8046755000 ext 1570 jessica.lehosit@va.gov Less << |
| NCT00337558 | Overactive Bladder ... More >> Urinary Incontinence Urge Incontinence Less << | Phase 4 | Completed | - | - |
| NCT01642277 | Overactive Bladder | PHASE2 | COMPLETED | 2025-08-14 | Loyola University Chicago Heal... More >>th Sciences Division, Maywood, Illinois, 60153, United States Less << |
| NCT00821184 | Overactive Bladder | Phase 3 | Terminated(Insufficient subjec... More >>t availability/findings for data analysis) Less << | - | United States, Massachusetts ... More >> Lahey Clinic Burlington, Massachusetts, United States, 01805 Less << |
| NCT00821184 | - | Terminated(Insufficient subjec... More >>t availability/findings for data analysis) Less << | - | - | |
| NCT00507455 | - | Completed | - | - | |
| NCT01314781 | Overactive Bladder | Phase 4 | Completed | - | Switzerland ... More >> Blasenzentrum, Cantonal Hospital Frauenfeld, Thurgau, Switzerland, 8501 Less << |
| NCT01262391 | Urinary Bladder, Overactive | Phase 1 | Completed | - | Belgium ... More >> Ghent, Belgium, 9000 Kortrijk, Belgium, 8500 Denmark Arhus, Denmark, 8200 Sweden Goteborg, Sweden, 41685 Uppsala, Sweden, 75185 United Kingdom Cambridge, United Kingdom, CB2 2QQ Manchester, United Kingdom, M13 9WL Sheffield, United Kingdom, S10 2TH Less << |
| NCT01018264 | Overactive Bladder in Parkinso... More >>n's Disease Less << | Phase 4 | Completed | - | United States, Florida ... More >> University of Miami Miami, Florida, United States, 33136 University of South Florida Tampa, Florida, United States, 33612 United States, Georgia Emory University Atlanta, Georgia, United States, 30329 Less << |
| NCT01943487 | Drug-Drug Interaction (DDI) ... More >> Healthy Subjects Less << | Phase 1 | Completed | - | France ... More >> SGS Aster Paris, France, 75015 Less << |
| NCT01018264 | - | Completed | - | - | |
| NCT00507455 | Lower Urinary Tract Symptoms ... More >> Bladder Outlet Obstruction Less << | Phase 2 | Completed | - | - |
| NCT01638000 | Urologic Diseases ... More >> Urinary Bladder, Overactive Urinary Bladder Diseases Less << | Phase 3 | Completed | - | - |
| NCT01595152 | Urinary Bladder, Overactive | Not Applicable | Unknown | May 2013 | Israel ... More >> Rambam Health Care Campus Recruiting Haifa, Israel Contact: Lior Lowenstein, MD 048542382 lowensteinmd@gmailc.om Hadassah Not yet recruiting Jerusalem, Israel Contact: David Shveiky, MD 97248542653 dshveiky@gmail.com Principal Investigator: David Shveiky, MD Belinson Not yet recruiting Petach Tikva, Israel Contact: Haim Krissi, MD 97248542653 haimkrissi@hotmail.com Principal Investigator: Haim Krissi, MD Asaf harofeh Not yet recruiting Tel Aviv, Israel Contact: Anna Padoa, MD 97248542653 annapadoa@gmail.com Principal Investigator: Anna Padoa, MD Rebecca Ziv Not yet recruiting Zefat, Israel Contact: Naama Marcus, MD 97248542653 naama.m@ziv.health.gov.il Principal Investigator: Naama Marcus, MD Less << |
| NCT01215721 | - | Completed | - | - | |
| NCT00463541 | Urinary Bladder, Overactive | Phase 3 | Completed | - | - |
| NCT00431041 | - | Completed | - | - | |
| NCT02045862 | Urinary Bladder Overactive ... More >> Overactive Bladder Urgency Incontinence Urinary Bladder Diseases\Urologic Diseases Less << | Phase 3 | Completed | - | - |
| NCT02010944 | Phase 1 Bioav... More >>ailability Healthy Subjects Less << | Phase 1 | Completed | - | Germany ... More >> Parexel Berlin, Germany, 14050 Less << |
| NCT02045862 | - | Completed | - | - | |
| NCT00431041 | Overactive Bladder | Phase 4 | Completed | - | Canada, Alberta ... More >> Calgary, Alberta, Canada, T2V 4R6 Edmonton, Alberta, Canada, T5H 3V9 Canada, British Columbia Vancouver, British Columbia, Canada, V6T 2B5 Victoria, British Columbia, Canada, V8T 5G1 Canada, Nova Scotia Halifax, Nova Scotia, Canada, B3H 3A7 Canada, Ontario Guelph, Ontario, Canada, N1H 5J1 Kitchener, Ontario, Canada, N2N 2B9 Toronto, Ontario, Canada, M4N 3M5 Toronto, Ontario, Canada, M5G 1Z5 Toronto, Ontario, Canada, M5T 2S8 Toronto, Ontario, Canada, M6A 3B5 Canada, Quebec Montreal, Quebec, Canada, H3T 1E2 Less << |
| NCT03558919 | Overactive Bladder | Phase 4 | Completed | - | Bangladesh ... More >> Bangabandhu Sheikh Mujib Medical University Dhaka, Bangladesh, 1100 Less << |
| NCT01215721 | Urinary Incontinence | Not Applicable | Completed | - | United States, California ... More >> University of California, Irvine Medical Center Orange, California, United States, 92868 Less << |
| NCT01092624 | Pelvic Organ Prolapse | Phase 4 | Terminated(sponsor closed stud... More >>y due to poor enrollment) Less << | - | United States, Connecticut ... More >> Hartford Hospital Hartford, Connecticut, United States, 06106 Less << |
| NCT00581061 | Incontinence | Not Applicable | Terminated(Study subjects were... More >> not compliant with study protocols.) Less << | - | United States, California ... More >> University of California, Irvine Medical Center Orange, California, United States, 92868 Less << |
| NCT00979472 | Urinary Bladder, Overactive|Ov... More >>eractive Bladder Less << | PHASE4 | COMPLETED | 2025-06-10 | Daegu, 700-712, Korea, Republi... More >>c of|Daegu, 705-718, Korea, Republic of|Daejon, 301-721, Korea, Republic of|Inchon, 400-711, Korea, Republic of|Jeonnam, 519-809, Korea, Republic of|Pusan, 602-739, Korea, Republic of|Seoul, 135-170, Korea, Republic of|Seoul, 135-705, Korea, Republic of|Seoul, 138-736, Korea, Republic of Less << |
| NCT00581061 | - | Terminated(Study subjects were... More >> not compliant with study protocols.) Less << | - | - | |
| NCT01747577 | Overactive Bladder ... More >> Benign Prostate Hyperplasia Transurethral Resection of Prostate Photoselective Vaporization Prostatectomy Less << | Phase 4 | Completed | - | Korea, Republic of ... More >> Soul, Korea, Republic of Less << |
| NCT02047032 | Urinary Incontinence | Not Applicable | Completed | - | China ... More >> Guang'an Men Hospotal Affiliated to China Academy of Chinese Medical Sciences Beijing, China, 100053 Less << |
| NCT00454740 | Urinary Bladder, Overactive | Phase 3 | Completed | - | - |
| NCT01638000 | - | Completed | - | - | |
| NCT01423838 | Overactive Bladder | Phase 4 | Unknown | September 2012 | Turkey ... More >> Turkish Republic Ministry of Health Adana Numune Training and Research Hospital Not yet recruiting Adana, Turkey, 01150 Contact: Murat Api, M.D., Ph.D. +905424241807 muratapi@hotmail.com Contact: Hakan Aytan, M.D. +905056833866 drhakanaytan@yahoo.com Less << |
| NCT01318837 | Over Active Bladder | Phase 4 | Completed | - | Korea, Republic of ... More >> Seoul, Korea, Republic of Sungnam, Korea, Republic of Less << |
| NCT02180997 | LUTS Benign P... More >>rostatic Hyperplasia Overactive Bladder Less << | Phase 1 | Completed | - | Korea, Republic of ... More >> Seoul National University Hospital(SNUH) Seoul, Jongno-Gu, Korea, Republic of, 110-744 Less << |
| NCT01833663 | Overactive Bladder ... More >> Postmenopausal Disorder Urination Disorders Less << | Phase 4 | Completed | - | China, Beijing ... More >> Peking Union Medical College Hospital Beijing, Beijing, China, 100730 Less << |
| NCT01489709 | - | Completed | - | Japan ... More >> Chubu, Japan Chugoku, Japan Hokkaido, Japan Kansai, Japan Kantou, Japan Kyushu, Japan Shikoku, Japan Touhoku, Japan Less << | |
| NCT00773552 | Urinary Urge ... More >>Urge Incontinence Overactive Bladder Less << | Phase 4 | Withdrawn(Investigator Left In... More >>stitution) Less << | - | United States, Connecticut ... More >> Optimus Health care Stamford, Connecticut, United States, 06904 The Stamford Hospital Stamford, Connecticut, United States, 06904 Less << |
| NCT01565694 | Neurogenic Detrusor Overactivi... More >>ty Less << | Phase 3 | Completed | - | United States, New York ... More >> Site US1008 Tarrytown, New York, United States, 10591 United States, Ohio Site US1010 Cincinnati, Ohio, United States, 45229-3039 Belgium Site BE3201 Gent, Belgium, 9000 Brazil Site BR5505 Sao Jose do Rio Preto, São Paulo, Brazil, 15090-000 Site BR5507 Campinas, Brazil, 13060-803 Site BR5504 Campinas, Brazil, 13083-887 Site BR5506 Curitiba, Brazil, 80240-060 Site BR5503 Porto Alegre, Brazil, 90035-903 Denmark Site DK4501 Aarhus, Denmark, 8200 Hungary Site HU3602 Miskolc, Hungary, 3526 Korea, Republic of Site KR8207 Seoul, Korea, Republic of, 110744 Site KR8201 Seoul, Korea, Republic of, 120752 Mexico Site MX5203 Leon, Mexico, 37000 Site MX5205 Mexico City, Mexico, C.P. 06700 Philippines Site PH6301 Manila, Philippines, 1015 Site PH6302 Quezon City, Philippines, 1101 Poland Site PL4803 Gdansk, Poland, 80-952 Site PL4805 Gdansk, Poland, 80803 Site PL4801 Warszawa, Poland, 04-730 Turkey Site TR9003 Ankara, Turkey, 6100 Site TR9002 Izmir, Turkey, 35100 Less << |
| NCT01565707 | Urinary Bladder, Overactive | Phase 3 | Completed | - | - |
| NCT01565707 | - | Completed | - | - | |
| NCT01406158 | Pharmacokinetics of Solifenaci... More >>n Succinate Healthy Volunteers Less << | Phase 1 | Completed | - | United States, Wisconsin ... More >> Spaulding Clinical Research West Bend, Wisconsin, United States, 53095 Less << |
| NCT02715024 | Lower Urinary Tract Symptoms ... More >> Overactive Bladder Benign Prostatic Hyperplasia (BPH) Less << | Phase 4 | Completed | - | Taiwan ... More >> Site Taipei, Taiwan Less << |
| NCT02972268 | Lower Urinary Tract Symptoms ... More >> Benign Prostatic Hyperplasia Less << | Phase 3 | Unknown | December 2017 | Korea, Republic of ... More >> Asan Medical Center Recruiting Seoul, Korea, Republic of Contact: Myung Soo Choo, MD., Ph.D Less << |
| NCT03468465 | Urinary Incontinence | Phase 4 | Active, not recruiting | March 2019 | Spain ... More >> Hospital Clínico Universtario Virgen de la Arrixaca El Palmar, Murcia, Spain, 30120 Less << |
| NCT02087098 | Urinary Bladder, Overactive | COMPLETED | 2025-03-16 | Site CZ42003 Private Practice,... More >> Bene?ov, Czech Republic|Site CZ42001 Private Practice, Beroun, Czech Republic|Site CZ42014 Private Practice, Blansko, Czech Republic|Site CZ42023 Private Practice, Boskovice, Czech Republic|Site CZ42032 Private Practice, Brno, Czech Republic|Site CZ42034 Hospital, Brno, Czech Republic|Site CZ42035 Private Practice, Brno, Czech Republic|Site CZ42036 Private Practice, Brno, Czech Republic|Site CZ42038 Private Practice, Brno, Czech Republic|Site CZ42039 Private Practice, Brno, Czech Republic|Site CZ42058 Hospital, Brno, Czech Republic|Site CZ42059 Hospital, Brno, Czech Republic|Site CZ42025 Private Practice, Cheb, Czech Republic|Site CZ42048 Private Practice, Dv?r Králové, Czech Republic|Site CZ42040 Private Practice, Havlí?k?v Brod, Czech Republic|Site CZ42015 Private Practice, Hodonín, Czech Republic|Site CZ42045 Private Practice, Hradec Králové, Czech Republic|Site CZ42027 Private Practice, Jind?ich?v Hradec, Czech Republic|Site CZ42029 Private Practice, Jind?ich?v Hradec, Czech Republic|Site CZ42051 Private Practice, Ji?ín, Czech Republic|Site CZ42026 Private Practice, Karlovy Vary, Czech Republic|Site CZ42028 Private Practice, Karlovy Vary, Czech Republic|Site CZ42030 Private Practice, Klatovy, Czech Republic|Site CZ42049 Private Practice, Litomě?ice, Czech Republic|Site CZ42021 Private Practice, Litovel, Czech Republic|Site CZ42050 Private Practice, Most, Czech Republic|Site CZ42054 Private Practice, Ostrava, Czech Republic|Site CZ42055 Private Practice, Ostrava, Czech Republic|Site CZ42056 Private Practice, Ostrava, Czech Republic|Site CZ42057 Private Practice, Ostrava, Czech Republic|Site CZ42005 Private Practice, Pardubice, Czech Republic|Site CZ42008 Private Practice, Pardubice, Czech Republic|Site CZ42024 Private Practice, Plzeň, Czech Republic|Site CZ42011 Private Practice, Praha 10, Czech Republic|Site CZ42006 Private Practice, Praha 2, Czech Republic|Site CZ42010 Private Practice, Praha 4, Czech Republic|Site CZ42009 Private Practice, Praha 5, Czech Republic|Site CZ42004 Private Practice, Praha 7, Czech Republic|Site CZ42002 Private Practice, Praha 8, Czech Republic|Site CZ42007 Private Practice, Praha 8, Czech Republic|Site CZ42060 Private Practice, Praha, Czech Republic|Site CZ42044 Private Practice, Roudnice nad Labem, Czech Republic|Site CZ42031 Private Practice, Strakonice, Czech Republic|Site CZ42020 Private Practice, Svitavy, Czech Republic|Site CZ42047 Private Practice, Teplice, Czech Republic|Site CZ42053 Private Practice, Teplice, Czech Republic|Site CZ42042 Private Practice, Trutnov, Czech Republic|Site CZ42052 Private Practice, Turnov, Czech Republic|Site CZ42018 Hospital, Uherské Hradi?tě, Czech Republic|Site CZ42019 Private Practice, Uherské Hradi?tě, Czech Republic|Site CZ42041 Hospital, Velké Mezi?í?í, Czech Republic|Site CZ42016 Private Practice, Vsetín, Czech Republic|Site CZ42017 Private Practice, Vsetín, Czech Republic|Site CZ42012 Private Practice, Zlín, Czech Republic|Site CZ42013 Private Practice, Zlín, Czech Republic|Site CZ42022 Private Practice, Zlín, Czech Republic|Site CZ42033 Private Practice, Znojmo, Czech Republic|Site CZ42037 Hospital, Znojmo, Czech Republic|Site CZ42043 Private Practice, ústí nad Labem, Czech Republic|Site CZ42046 Private Practice, ústí nad Labem, Czech Republic Less << | |
| NCT02827578 | Benign Prostate Hyperplasia | Phase 3 | Unknown | December 2017 | Korea, Republic of ... More >> Samsung medical center Recruiting Seoul, Korea, Republic of Principal Investigator: Kyu Sung Lee Less << |
| NCT02805452 | Overactive Bladder | Phase 3 | Terminated(Target of recruitme... More >>nt not reachable) Less << | - | France ... More >> Clinique Pasteur Lanroze Brest, France CH Bretagne Sud Lorient, France CH Lyon Sud Lyon, France Hôpital Saint Louis Paris, France Centre Eugene Marquis Rennes, France, 35042 Less << |
| NCT01297192 | Healthy Volunteers ... More >> Pharmacokinetics of Mirabegron Less << | Phase 1 | Completed | - | France ... More >> Paris, France, 75015 Less << |
| NCT01777217 | Over-Active Bladder | Phase 4 | Terminated(Terminated) | - | United States, Texas ... More >> Century Cancer Center Houston, Texas, United States, 77025 Less << |
| NCT01745094 | - | Completed | - | - | |
| NCT01777217 | - | Terminated(Terminated) | - | - | |
| NCT01745094 | Overactive Bladder | Phase 4 | Completed | - | Japan ... More >> Chubu, Japan Hokkaido, Japan Kansai, Japan Kantou, Japan Kyushu, Japan Less << |
| NCT01371994 | Urinary Incontinence | Phase 4 | Completed | - | - |
| NCT01533597 | Overactive Bladder | Phase 4 | Completed | - | Korea, Republic of ... More >> Soonchunhyang University Bucheon Hospital Bucheon, Gyeonggi-do, Korea, Republic of, 420-767 Less << |
| NCT01533597 | - | Completed | - | - | |
| NCT01371994 | - | Completed | - | - | |
| NCT01093534 | Detrusor Overactivity ... More >> Overactive Bladder Less << | Phase 4 | Completed | - | - |
| NCT01876186 | Overactive Bladder Syndrome | Phase 4 | Unknown | December 2015 | Taiwan ... More >> Department of Obstetrics & Gynecology, National Taiwan University Hospital Recruiting Taipei, Taiwan, 100 Contact: Ho-Hsiung Lin, MD, PhD +886-2-23123456 ext 71557 hhlin@ntuh.gov.tw Principal Investigator: Ho-Hsiung Lin, MD, PhD Less << |
| NCT02169713 | Healthy Subjects ... More >> Pharmacokinetics Drug-Drug Interaction (DDI) Less << | Phase 1 | Completed | - | Germany ... More >> Parexel International GmbH Berlin, Germany, 14050 Less << |
| NCT01093534 | - | Completed | - | - | |
| NCT00884104 | Overactive Bladder | PHASE4 | COMPLETED | 2025-12-10 | Cheon-ju, Korea, Republic of|C... More >>hoongju, Korea, Republic of|Daegu, Korea, Republic of|Daejeon, Korea, Republic of|Kangneung, Korea, Republic of|Kwang-ju, Korea, Republic of|Pusan, Korea, Republic of|Seoul, Korea, Republic of|Suwon, Korea, Republic of Less << |
| NCT01470001 | Post-micturition Incontinence ... More >> Incontinence Less << | Not Applicable | Completed | - | United States, Wisconsin ... More >> UW Hospital and Clinics Madison, Wisconsin, United States, 53792 Less << |
| NCT01953887 | EC905 Pharmac... More >>okinetics Healthy Subjects Less << | Phase 1 | Completed | - | United Kingdom ... More >> Parexel London, United Kingdom, HA1 3UJ Less << |
| NCT02540707 | Overactive Bladder Syndrome | Phase 4 | Unknown | September 2016 | Taiwan ... More >> Outpatient clinics, Department of Obs/Gyn, National Taiwan University Hospital Recruiting Taipei, Taiwan, 100 Contact: Ho-Hsiung Lin, MD, PhD +886-2-23123456 ext 71557 hhlin@ntuh.gov.tw Less << |
| NCT01470001 | - | Completed | - | - | |
| NCT01505439 | Stress Urinary Incontinence ... More >> Urgency Urinary Incontinence Less << | Phase 4 | Completed | - | Korea, Republic of ... More >> Site KR00001 Chonam, Korea, Republic of Site KR00002 Chungnam, Korea, Republic of Site KR00003 Daegu, Korea, Republic of SIte KR00004 Incheon, Korea, Republic of Site KR00005 Pusan, Korea, Republic of Site KR00006 Seoul, Korea, Republic of Less << |
| NCT02127034 | Healthy Subjects ... More >> Pharmacokinetics Drug-Drug Interaction (DDI) Less << | Phase 1 | Completed | - | Germany ... More >> Parexel International GmbH Berlin, Germany, 14050 Less << |
| NCT01530373 | Hot Flashes B... More >>reast Cancer Less << | Phase 2 | Recruiting | September 2021 | United States, Arkansas ... More >> Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences Recruiting Little Rock, Arkansas, United States, 722205 Contact: Allen C Sherman, PhD 501-686-8700 shermanallenc@uams.edu Sub-Investigator: Issam Makhoul, MD Sub-Investigator: Laura Hutchins, MD Sub-Investigator: Rhonda Henry-Tillman, MD Less << |
| NCT01764893 | Overactive Bladder | Phase 4 | Terminated(Enrolling too slowl... More >>y due to insurance plans no longer covering the cost of the Percutaneous Tibial Nerve Stimulation treatment.) Less << | - | United States, Massachusetts ... More >> Bay State Clinical Trials, Inc. Watertown, Massachusetts, United States, 02472 Less << |
| NCT01437670 | - | Completed | - | Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of, 138-222 Less << | |
| NCT01015040 | Bioavailability of Solifenacin... More >> Succinate Pharmacokinetics of Solifenacin Succinate Healthy Volunteers Less << | Phase 1 | Completed | - | United States, Wisconsin ... More >> West Bend, Wisconsin, United States, 53095 Less << |
| NCT01981954 | Neurogenic Detrusor Overactivi... More >>ty Pediatric Less << | Phase 3 | Completed | - | United States, New York ... More >> Site US1008 Pediatric Urology Associates, P.C. Tarrytown, New York, United States, 10591 Belgium Site BE3203 Gent University Hospital Gent, Belgium, 9000 Korea, Republic of Site KR8207 Seoul National University Hospital Seoul, Korea, Republic of, 110744 Site KR8201 Severance Hospital Seoul, Korea, Republic of, 120752 Philippines Site PH6301 Philippines Children's Medical Center Manila, Philippines, 1015 Poland Site PL4803 Uniwersyteckie Centrum Kliniczne Gdansk, Poland, 81-211 Site PL4801 Pomnik-Centrum Zdrowia Dziecka Warszawa, Poland, 04-730 United Kingdom Site GB4401 Sheffield Children's Hospital Sheffield, United Kingdom, S10 2TN Less << |
| NCT00985387 | Urinary Bladder, Overactive|Ov... More >>eractive Bladder Less << | COMPLETED | 2025-08-11 | Bucheon, 420-717, Korea, Repub... More >>lic of|Bucheon, 420-767, Korea, Republic of|Busan, 602-702, Korea, Republic of|Busan, 602-715, Korea, Republic of|Busan, 602-739, Korea, Republic of|Busan, 614-735, Korea, Republic of|Chonju, 361-711, Korea, Republic of|Chonju, 380-704, Korea, Republic of|Chuncheon, 200-704, Korea, Republic of|Daegu, 700-712, Korea, Republic of|Daegu, 700-721, Korea, Republic of|Daegu, 705-717, Korea, Republic of|Daegu, 705-718, Korea, Republic of|Daejeon, 301-721, Korea, Republic of|Daejeon, 302-718, Korea, Republic of|Daejeon, 302-799, Korea, Republic of|Gangneung, 201-711, Korea, Republic of|Gumi-si, 730-728, Korea, Republic of|Gwangju, 501-717, Korea, Republic of|Gwangju, 501-757, Korea, Republic of|Gwangju, 503-715, Korea, Republic of|Gyongju, 780-350, Korea, Republic of|Hwasun, 519-809, Korea, Republic of|Iksan, 570-160, Korea, Republic of|Inchon, 400-711, Korea, Republic of|Inchon, 405-760, Korea, Republic of|Jeonju, 561-712, Korea, Republic of|Masan, 630-522, Korea, Republic of|Seongnam, 463-707, Korea, Republic of|Seoul, 100-380, Korea, Republic of|Seoul, 110-744, Korea, Republic of|Seoul, 130-702, Korea, Republic of|Seoul, 133-792, Korea, Republic of|Seoul, 136-705, Korea, Republic of|Seoul, 137-701, Korea, Republic of|Seoul, 138-736, Korea, Republic of|Seoul, 139-711, Korea, Republic of|Seoul, 143-729, Korea, Republic of|Seoul, 158-710, Korea, Republic of|Suwon, 443-721, Korea, Republic of|Ulsan, 682-714, Korea, Republic of Less << | |
| NCT01655069 | - | Completed | - | - | |
| NCT01981954 | - | Completed | - | - | |
| NCT01655069 | Urinary Bladder, Overactive | Phase 3 | Completed | - | - |
| NCT03632772 | Overactive Bladder Syndrome | Phase 2 | Recruiting | July 31, 2019 | Taiwan ... More >> Buddhist Tzu Chi General Hospital Recruiting Hualien city, Taiwan, 970 Contact: Hann-Chorng Kuo, M.D. 886-3-8561825 ext 2113 hck@tzuchi.com.tw Less << |
| NCT01627145 | Overactive Bladder Syndrome | UNKNOWN | 2025-07-15 | No 8, Chung-Shan South Road,, ... More >>Taipei, 100, Taiwan Less << | |
| NCT01559389 | Urge Urinary Incontinence | PHASE4 | COMPLETED | 2017-06-29 | Loyola University Medical Cent... More >>er, Maywood, Illinois, 60153, United States Less << |
| Bio Calculators | ||||
| Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.76mL 0.55mL 0.28mL |
13.79mL 2.76mL 1.38mL |
27.59mL 5.52mL 2.76mL |
|
| Dissolving Methods |
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:
in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day; The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
|
|||